Global Zoster Vaccine Live Market Growth 2022-2028
- LP 4835209
- 70 Pages
- February 2022
- Pharmaceuticals
The United States Zoster Vaccine Live market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Zoster Vaccine Live market, reaching US$ million by the year 2028. As for the Europe Zoster Vaccine Live landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Zoster Vaccine Live players cover Merck, GSK, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Zoster Vaccine Live market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Monovalent Vaccine
Combination Vaccine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Kids Injection
Adults Injection
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
GSK
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Zoster Vaccine Live Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Zoster Vaccine Live by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Zoster Vaccine Live by Country/Region, 2017, 2022 & 2028
2.2 Zoster Vaccine Live Segment by Type
2.2.1 Monovalent Vaccine
2.2.2 Combination Vaccine
2.3 Zoster Vaccine Live Sales by Type
2.3.1 Global Zoster Vaccine Live Sales Market Share by Type (2017-2022)
2.3.2 Global Zoster Vaccine Live Revenue and Market Share by Type (2017-2022)
2.3.3 Global Zoster Vaccine Live Sale Price by Type (2017-2022)
2.4 Zoster Vaccine Live Segment by Application
2.4.1 Kids Injection
2.4.2 Adults Injection
2.5 Zoster Vaccine Live Sales by Application
2.5.1 Global Zoster Vaccine Live Sale Market Share by Application (2017-2022)
2.5.2 Global Zoster Vaccine Live Revenue and Market Share by Application (2017-2022)
2.5.3 Global Zoster Vaccine Live Sale Price by Application (2017-2022)
3 Global Zoster Vaccine Live by Company
3.1 Global Zoster Vaccine Live Breakdown Data by Company
3.1.1 Global Zoster Vaccine Live Annual Sales by Company (2020-2022)
3.1.2 Global Zoster Vaccine Live Sales Market Share by Company (2020-2022)
3.2 Global Zoster Vaccine Live Annual Revenue by Company (2020-2022)
3.2.1 Global Zoster Vaccine Live Revenue by Company (2020-2022)
3.2.2 Global Zoster Vaccine Live Revenue Market Share by Company (2020-2022)
3.3 Global Zoster Vaccine Live Sale Price by Company
3.4 Key Manufacturers Zoster Vaccine Live Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Zoster Vaccine Live Product Location Distribution
3.4.2 Players Zoster Vaccine Live Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Zoster Vaccine Live by Geographic Region
4.1 World Historic Zoster Vaccine Live Market Size by Geographic Region (2017-2022)
4.1.1 Global Zoster Vaccine Live Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Zoster Vaccine Live Annual Revenue by Geographic Region
4.2 World Historic Zoster Vaccine Live Market Size by Country/Region (2017-2022)
4.2.1 Global Zoster Vaccine Live Annual Sales by Country/Region (2017-2022)
4.2.2 Global Zoster Vaccine Live Annual Revenue by Country/Region
4.3 Americas Zoster Vaccine Live Sales Growth
4.4 APAC Zoster Vaccine Live Sales Growth
4.5 Europe Zoster Vaccine Live Sales Growth
4.6 Middle East & Africa Zoster Vaccine Live Sales Growth
5 Americas
5.1 Americas Zoster Vaccine Live Sales by Country
5.1.1 Americas Zoster Vaccine Live Sales by Country (2017-2022)
5.1.2 Americas Zoster Vaccine Live Revenue by Country (2017-2022)
5.2 Americas Zoster Vaccine Live Sales by Type
5.3 Americas Zoster Vaccine Live Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Zoster Vaccine Live Sales by Region
6.1.1 APAC Zoster Vaccine Live Sales by Region (2017-2022)
6.1.2 APAC Zoster Vaccine Live Revenue by Region (2017-2022)
6.2 APAC Zoster Vaccine Live Sales by Type
6.3 APAC Zoster Vaccine Live Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Zoster Vaccine Live by Country
7.1.1 Europe Zoster Vaccine Live Sales by Country (2017-2022)
7.1.2 Europe Zoster Vaccine Live Revenue by Country (2017-2022)
7.2 Europe Zoster Vaccine Live Sales by Type
7.3 Europe Zoster Vaccine Live Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Zoster Vaccine Live by Country
8.1.1 Middle East & Africa Zoster Vaccine Live Sales by Country (2017-2022)
8.1.2 Middle East & Africa Zoster Vaccine Live Revenue by Country (2017-2022)
8.2 Middle East & Africa Zoster Vaccine Live Sales by Type
8.3 Middle East & Africa Zoster Vaccine Live Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Zoster Vaccine Live
10.3 Manufacturing Process Analysis of Zoster Vaccine Live
10.4 Industry Chain Structure of Zoster Vaccine Live
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Zoster Vaccine Live Distributors
11.3 Zoster Vaccine Live Customer
12 World Forecast Review for Zoster Vaccine Live by Geographic Region
12.1 Global Zoster Vaccine Live Market Size Forecast by Region
12.1.1 Global Zoster Vaccine Live Forecast by Region (2023-2028)
12.1.2 Global Zoster Vaccine Live Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Zoster Vaccine Live Forecast by Type
12.7 Global Zoster Vaccine Live Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Zoster Vaccine Live Product Offered
13.1.3 Merck Zoster Vaccine Live Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
14 Research Findings and Conclusion
Table 1. Zoster Vaccine Live Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Zoster Vaccine Live Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Monovalent Vaccine
Table 4. Major Players of Combination Vaccine
Table 5. Global Zoster Vaccine Live Sales by Type (2017-2022) & (K Doses)
Table 6. Global Zoster Vaccine Live Sales Market Share by Type (2017-2022)
Table 7. Global Zoster Vaccine Live Revenue by Type (2017-2022) & ($ million)
Table 8. Global Zoster Vaccine Live Revenue Market Share by Type (2017-2022)
Table 9. Global Zoster Vaccine Live Sale Price by Type (2017-2022) & (US$/Dose)
Table 10. Global Zoster Vaccine Live Sales by Application (2017-2022) & (K Doses)
Table 11. Global Zoster Vaccine Live Sales Market Share by Application (2017-2022)
Table 12. Global Zoster Vaccine Live Revenue by Application (2017-2022)
Table 13. Global Zoster Vaccine Live Revenue Market Share by Application (2017-2022)
Table 14. Global Zoster Vaccine Live Sale Price by Application (2017-2022) & (US$/Dose)
Table 15. Global Zoster Vaccine Live Sales by Company (2020-2022) & (K Doses)
Table 16. Global Zoster Vaccine Live Sales Market Share by Company (2020-2022)
Table 17. Global Zoster Vaccine Live Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Zoster Vaccine Live Revenue Market Share by Company (2020-2022)
Table 19. Global Zoster Vaccine Live Sale Price by Company (2020-2022) & (US$/Dose)
Table 20. Key Manufacturers Zoster Vaccine Live Producing Area Distribution and Sales Area
Table 21. Players Zoster Vaccine Live Products Offered
Table 22. Zoster Vaccine Live Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Zoster Vaccine Live Sales by Geographic Region (2017-2022) & (K Doses)
Table 26. Global Zoster Vaccine Live Sales Market Share Geographic Region (2017-2022)
Table 27. Global Zoster Vaccine Live Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Zoster Vaccine Live Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Zoster Vaccine Live Sales by Country/Region (2017-2022) & (K Doses)
Table 30. Global Zoster Vaccine Live Sales Market Share by Country/Region (2017-2022)
Table 31. Global Zoster Vaccine Live Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Zoster Vaccine Live Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Zoster Vaccine Live Sales by Country (2017-2022) & (K Doses)
Table 34. Americas Zoster Vaccine Live Sales Market Share by Country (2017-2022)
Table 35. Americas Zoster Vaccine Live Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Zoster Vaccine Live Revenue Market Share by Country (2017-2022)
Table 37. Americas Zoster Vaccine Live Sales by Type (2017-2022) & (K Doses)
Table 38. Americas Zoster Vaccine Live Sales Market Share by Type (2017-2022)
Table 39. Americas Zoster Vaccine Live Sales by Application (2017-2022) & (K Doses)
Table 40. Americas Zoster Vaccine Live Sales Market Share by Application (2017-2022)
Table 41. APAC Zoster Vaccine Live Sales by Region (2017-2022) & (K Doses)
Table 42. APAC Zoster Vaccine Live Sales Market Share by Region (2017-2022)
Table 43. APAC Zoster Vaccine Live Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Zoster Vaccine Live Revenue Market Share by Region (2017-2022)
Table 45. APAC Zoster Vaccine Live Sales by Type (2017-2022) & (K Doses)
Table 46. APAC Zoster Vaccine Live Sales Market Share by Type (2017-2022)
Table 47. APAC Zoster Vaccine Live Sales by Application (2017-2022) & (K Doses)
Table 48. APAC Zoster Vaccine Live Sales Market Share by Application (2017-2022)
Table 49. Europe Zoster Vaccine Live Sales by Country (2017-2022) & (K Doses)
Table 50. Europe Zoster Vaccine Live Sales Market Share by Country (2017-2022)
Table 51. Europe Zoster Vaccine Live Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Zoster Vaccine Live Revenue Market Share by Country (2017-2022)
Table 53. Europe Zoster Vaccine Live Sales by Type (2017-2022) & (K Doses)
Table 54. Europe Zoster Vaccine Live Sales Market Share by Type (2017-2022)
Table 55. Europe Zoster Vaccine Live Sales by Application (2017-2022) & (K Doses)
Table 56. Europe Zoster Vaccine Live Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Zoster Vaccine Live Sales by Country (2017-2022) & (K Doses)
Table 58. Middle East & Africa Zoster Vaccine Live Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Zoster Vaccine Live Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Zoster Vaccine Live Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Zoster Vaccine Live Sales by Type (2017-2022) & (K Doses)
Table 62. Middle East & Africa Zoster Vaccine Live Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Zoster Vaccine Live Sales by Application (2017-2022) & (K Doses)
Table 64. Middle East & Africa Zoster Vaccine Live Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Zoster Vaccine Live
Table 66. Key Market Challenges & Risks of Zoster Vaccine Live
Table 67. Key Industry Trends of Zoster Vaccine Live
Table 68. Zoster Vaccine Live Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Zoster Vaccine Live Distributors List
Table 71. Zoster Vaccine Live Customer List
Table 72. Global Zoster Vaccine Live Sales Forecast by Region (2023-2028) & (K Doses)
Table 73. Global Zoster Vaccine Live Sales Market Forecast by Region
Table 74. Global Zoster Vaccine Live Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Zoster Vaccine Live Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Zoster Vaccine Live Sales Forecast by Country (2023-2028) & (K Doses)
Table 77. Americas Zoster Vaccine Live Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Zoster Vaccine Live Sales Forecast by Region (2023-2028) & (K Doses)
Table 79. APAC Zoster Vaccine Live Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Zoster Vaccine Live Sales Forecast by Country (2023-2028) & (K Doses)
Table 81. Europe Zoster Vaccine Live Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Zoster Vaccine Live Sales Forecast by Country (2023-2028) & (K Doses)
Table 83. Middle East & Africa Zoster Vaccine Live Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Zoster Vaccine Live Sales Forecast by Type (2023-2028) & (K Doses)
Table 85. Global Zoster Vaccine Live Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Zoster Vaccine Live Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Zoster Vaccine Live Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Zoster Vaccine Live Sales Forecast by Application (2023-2028) & (K Doses)
Table 89. Global Zoster Vaccine Live Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Zoster Vaccine Live Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Zoster Vaccine Live Revenue Market Share Forecast by Application (2023-2028)
Table 92. Merck Basic Information, Zoster Vaccine Live Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Zoster Vaccine Live Product Offered
Table 94. Merck Zoster Vaccine Live Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 95. Merck Main Business
Table 96. Merck Latest Developments
Table 97. GSK Basic Information, Zoster Vaccine Live Manufacturing Base, Sales Area and Its Competitors
Table 98. GSK Zoster Vaccine Live Product Offered
Table 99. GSK Zoster Vaccine Live Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 100. GSK Main Business
Table 101. GSK Latest Developments
List of Figures
Figure 1. Picture of Zoster Vaccine Live
Figure 2. Zoster Vaccine Live Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Zoster Vaccine Live Sales Growth Rate 2017-2028 (K Doses)
Figure 7. Global Zoster Vaccine Live Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Zoster Vaccine Live Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Monovalent Vaccine
Figure 10. Product Picture of Combination Vaccine
Figure 11. Global Zoster Vaccine Live Sales Market Share by Type in 2021
Figure 12. Global Zoster Vaccine Live Revenue Market Share by Type (2017-2022)
Figure 13. Zoster Vaccine Live Consumed in Kids Injection
Figure 14. Global Zoster Vaccine Live Market: Kids Injection (2017-2022) & (K Doses)
Figure 15. Zoster Vaccine Live Consumed in Adults Injection
Figure 16. Global Zoster Vaccine Live Market: Adults Injection (2017-2022) & (K Doses)
Figure 17. Global Zoster Vaccine Live Sales Market Share by Application (2017-2022)
Figure 18. Global Zoster Vaccine Live Revenue Market Share by Application in 2021
Figure 19. Zoster Vaccine Live Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Zoster Vaccine Live Revenue Market Share by Company in 2021
Figure 21. Global Zoster Vaccine Live Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Zoster Vaccine Live Revenue Market Share by Geographic Region in 2021
Figure 23. Global Zoster Vaccine Live Sales Market Share by Region (2017-2022)
Figure 24. Global Zoster Vaccine Live Revenue Market Share by Country/Region in 2021
Figure 25. Americas Zoster Vaccine Live Sales 2017-2022 (K Doses)
Figure 26. Americas Zoster Vaccine Live Revenue 2017-2022 ($ Millions)
Figure 27. APAC Zoster Vaccine Live Sales 2017-2022 (K Doses)
Figure 28. APAC Zoster Vaccine Live Revenue 2017-2022 ($ Millions)
Figure 29. Europe Zoster Vaccine Live Sales 2017-2022 (K Doses)
Figure 30. Europe Zoster Vaccine Live Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Zoster Vaccine Live Sales 2017-2022 (K Doses)
Figure 32. Middle East & Africa Zoster Vaccine Live Revenue 2017-2022 ($ Millions)
Figure 33. Americas Zoster Vaccine Live Sales Market Share by Country in 2021
Figure 34. Americas Zoster Vaccine Live Revenue Market Share by Country in 2021
Figure 35. United States Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Zoster Vaccine Live Sales Market Share by Region in 2021
Figure 40. APAC Zoster Vaccine Live Revenue Market Share by Regions in 2021
Figure 41. China Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Zoster Vaccine Live Sales Market Share by Country in 2021
Figure 48. Europe Zoster Vaccine Live Revenue Market Share by Country in 2021
Figure 49. Germany Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Zoster Vaccine Live Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Zoster Vaccine Live Revenue Market Share by Country in 2021
Figure 56. Egypt Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Zoster Vaccine Live Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Zoster Vaccine Live in 2021
Figure 62. Manufacturing Process Analysis of Zoster Vaccine Live
Figure 63. Industry Chain Structure of Zoster Vaccine Live
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
